http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2002042089-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2773a2aeb05b5eabdf9e74906a9c5076
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-244
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-00
classificationIPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P21-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-09
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-53
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-13
filingDate 2001-05-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9702d9f98cc6dc7fe2464396ace63541
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_18007be62ef6344512aec725a040d481
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0e21f32d8050cf4bd86d13ecc35a07af
publicationDate 2002-04-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-2002042089-A1
titleOfInvention Interleukin-5 specific recombinant antibodies
abstract An effective anti-IL-5 recombinant antibody molecule comprising heavy and/or light chain antigen-binding residues from a donor antibody.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10793628-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2010042562-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2016004045-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10421819-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11746159-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11560435-B2
priorityDate 1994-06-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23700614
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226541637
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5366546
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226409442
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23830
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11218679
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226495156
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9702
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394880
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226400531
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3034398
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226410798

Total number of triples: 49.